Read Trending Stories
- » Ultimate Market Recap: Talbots Tanks, Facebook Fiasco Continues
- » Are Facebook Losses Bigger Than Initially Thought?
- » Consumer Business Recap: Toyota Needs Emerging Markets, Wal-Mart's Express Update
- » Consumer Biz Recap: Talbots CRASHES HARD, Time Warner Eyes Sports Website
- » Your Cheat Sheet to Apple's Week of Stock Moving News
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Delcath Systems (DCTH)
- Mentor Graphics Corp (MENT)
- Complete Genomics (GNOM)
Amazon.com, Inc. (NASDAQ:AMZN): The number of Amazon’s (NASDAQ:AMZN) employees surged 67% at the end of December 2011 to 56,200 workers, up from 33,700 one year earlier, according to Gigaom, which cited the company’s 8-K filing. Shares of Amazon.com, Inc. are trading 9.86% lower today.
AOL, Inc. (NYSE:AOL): Reports Q4 revenue $576.8M vs. consensus $572.98M. Reports Q4 advertising revenue $373.8M, up 10% y/y. Reports Q4 subscription revenue down 18% y/y to $194.6M. Shares of AOL, Inc. are trading 14.56% higher today.
Aetna Inc. (NYSE:AET): Total medical benefit ratio was 80.7% in Q4 and 79.6% for the full year. Shares of Aetna Inc. are trading 4.26% higher today.
Medivation, Inc. (NASDAQ:MDVN): Wedbush raised its estimates and price target for Medivation after the company reported positive AFFIRM results. The firm believes the results confirm MDV3100′s promise as a treatment for prostate cancer and keeps an Outperform rating on the stock. Shares of Medivation, Inc. are trading 17.6% higher today.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com
To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!
Do You Want More Profits? Wall St. Cheat Sheet Premium newsletter subscribers have been crushing the markets with winning stock picks.
Click here now for your FREE trial to our acclaimed flagship newsletter:
